182 related articles for article (PubMed ID: 27167847)
1. Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Commentary.
Shore ND
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 5):17-9. PubMed ID: 27167847
[No Abstract] [Full Text] [Related]
2. Prostate cancer - Therapy with radium-223.
Brito AE; Amorim BJ; Martello M; Bernardo WM; Etchebehere E;
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1019-1023. PubMed ID: 29489974
[No Abstract] [Full Text] [Related]
3. CApecitabine plus Radium-223 (Xofigoâ„¢) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial.
Coleman R; Brown J; Rathbone E; Flanagan L; Reid A; Kendall J; Howell S; Twelves C; Palmieri C; Anand A; MacPherson I; Brown S
Trials; 2020 Jan; 21(1):89. PubMed ID: 31941523
[TBL] [Abstract][Full Text] [Related]
4. EMA guidance on radium-223 dichloride in prostate cancer.
Gourd E
Lancet Oncol; 2018 Apr; 19(4):e190. PubMed ID: 29551361
[No Abstract] [Full Text] [Related]
5. Management of bone metastases in prostate cancer: a review.
Bienz M; Saad F
Curr Opin Support Palliat Care; 2015 Sep; 9(3):261-7. PubMed ID: 26262831
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: ASCO Clinical Practice Guideline Summary.
Morris MJ; Rumble RB; Milowsky MI
J Oncol Pract; 2018 May; 14(5):319-322. PubMed ID: 29648921
[No Abstract] [Full Text] [Related]
7. Radium - 223 (Xofigo) for prostate cancer.
Med Lett Drugs Ther; 2013 Sep; 55(1426):79-80. PubMed ID: 24081388
[No Abstract] [Full Text] [Related]
8. Phase II Clinical Study of Radium-223 Chloride (BAY 88-8223) in Japanese Patients With Symptomatic Castration-Resistant Prostate Cancer (CRPC) With Bone Metastases.
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 5):15-6. PubMed ID: 27167846
[No Abstract] [Full Text] [Related]
9. Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety.
Nilsson S
Expert Opin Drug Saf; 2015 Jul; 14(7):1127-36. PubMed ID: 26022669
[TBL] [Abstract][Full Text] [Related]
10. Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC).
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 5):10-1. PubMed ID: 27167843
[No Abstract] [Full Text] [Related]
11. Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective.
Shore ND
Urology; 2015 Apr; 85(4):717-24. PubMed ID: 25681834
[TBL] [Abstract][Full Text] [Related]
12. New radiation therapy prolongs metastatic prostate cancer survival.
McBride D
ONS Connect; 2013 Sep; 28(3):49. PubMed ID: 24028051
[No Abstract] [Full Text] [Related]
13. Radium-223: the newest option in metastatic castration-resistant prostate cancer.
Sartor O
Clin Adv Hematol Oncol; 2013 Dec; 11(12):801-3. PubMed ID: 24893286
[No Abstract] [Full Text] [Related]
14. Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases.
Vogelzang NJ
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):809-819. PubMed ID: 28649893
[TBL] [Abstract][Full Text] [Related]
15. Highlights in advanced prostate cancer from the 2014 American Society of Clinical Oncology genitourinary cancers symposium: commentary.
George DJ
Clin Adv Hematol Oncol; 2014 Apr; 12(4 Suppl 11):12-6. PubMed ID: 24870260
[No Abstract] [Full Text] [Related]
16. Practical guide to the use of radium 223 dichloride.
Den RB; Doyle LA; Knudsen KE
Can J Urol; 2014 Apr; 21(2 Supp 1):70-6. PubMed ID: 24775727
[TBL] [Abstract][Full Text] [Related]
17. Updates on radium-223 for castration-resistant prostate cancer presented at the Genitourinary Cancers Symposium, January 7-9, 2016, San Francisco, California.
Barkin J
Can J Urol; 2016 Jun; 23(3):8306-7. PubMed ID: 27347626
[No Abstract] [Full Text] [Related]
18. Highlights in kidney cancer from the 2016 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2016 Aug; 14(8):594-6. PubMed ID: 27487102
[No Abstract] [Full Text] [Related]
19. Dosing, administration, and safety of radium-223: How I do it.
Dan TD; Doyle L; Raval AJ; Pridjian A; Gomella LG; Den RB
Can J Urol; 2016 Jun; 23(3):8301-5. PubMed ID: 27347625
[TBL] [Abstract][Full Text] [Related]
20. Use of radium-223 in men with metastatic castration-resistant prostate cancer.
Parker C
Clin Adv Hematol Oncol; 2015 Nov; 13(11):723-5. PubMed ID: 27058695
[No Abstract] [Full Text] [Related]
[Next] [New Search]